Literature DB >> 703406

Metabolism and haemolytic effect of dapsone and its metabolites in man.

J Halmekoski, M J Mattila, K K Mustakallio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 703406

Source DB:  PubMed          Journal:  Med Biol        ISSN： 0302-2137


× No keyword cloud information.
  4 in total

1.  The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

Authors:  M D Coleman; A K Scott; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 3.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

Review 4.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.